CNTA
Centessa Pharmaceuticals
CNTA
CNTA
117 hedge funds and large institutions have $1.62B invested in Centessa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $1.8B → $1.62B (-$174M)
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
39% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 31
Holders
117
Holding in Top 10
10
Calls
$8.54M
Puts
$2.02M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$18.4M | |
| 3 | +$15.5M | |
| 4 |
Millennium Management
New York
|
+$13.3M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$12.7M |
Top Sellers
| 1 | -$32.4M | |
| 2 | -$24M | |
| 3 | -$22.2M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$17.6M |
| 5 |
Morgan Stanley
New York
|
-$14.5M |